Emcure Pharmaceuticals Ltd. - Research Center

---

Results

• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 18

Sales

3,107.09

3,387.24

3,153.66

2,375.71

2,241.43

Operating profit

438.49

794.67

743.41

423.42

527.60

Interest

166.83

145.14

123.34

137.22

88.05

Gross profit

397.01

782.22

731.97

423.82

500.55

EPS (Rs)

8.85

24.71

23.25

9.69

13.42

Other income

125.35

132.68

111.91

137.62

61.00

Stock adjustment

14.45

-36.10

-107.96

59.70

60.34

Raw material

938.87

1,072.09

1,047.32

559.85

370.95

Power and fuel

-

-

-

-

-

Employee expenses

649.18

603.95

550.96

545.35

484.13

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

1,066.10

952.64

919.94

787.39

798.41

Provisions made

-

-

-

-

-

Depreciation

178.52

165.79

156.24

154.97

119.97

Taxation

52.28

169.61

136.97

49.48

99.68

Net profit / loss

160.06

446.81

420.48

175.21

242.77

Extra ordinary item

-6.15

-

-18.29

-44.16

-38.14

Prior year adjustments

-

-

-

-

-

Equity capital

180.85

180.85

180.85

180.85

180.85

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

14.11

23.46

23.57

17.82

23.54

GPM (%)

12.28

22.22

22.41

16.86

21.74

NPM (%)

4.95

12.69

12.88

6.97

10.54